Skip to main content
Smart Investors Daily
ConvaTec Group Plc logo

OTC · CNVVY

ConvaTec Group Plc

Healthcare · Medical - Instruments & Supplies

$12.22

Up+$0.41 (+3.47%)

Updated Oct 13, 2026, 5:48 AM

SID Score

5.8/10

Composite research score

Smart Money

46/100

Neutral

Market cap
6.28B
P/E ratio
28.99
Dividend yield
2.13%
52-week range
— – —
Volume
400
Avg. volume
24.37K

Price performance · CNVVY

CNVVY price history

1M range · 0 trading sessions · Daily adjusted prices

CNVVY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest CNVVY news

The latest Smart Investors Daily articles mentioning CNVVY.

CNVVY research

Overview

Company profile and research snapshot.

Company profile

CONVATEC GRP PLC UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$16.93
Implied upside
—
Analysts
21
CNVVY recent ratings
DateFirmRatingTarget
Jun 8, 2026JefferiesBuy—
May 22, 2026JP Morgan CazenoveOverweight—
May 18, 2026UBSBuy—
May 18, 2026CitigroupNeutral—
May 15, 2026JefferiesBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 6, 2026

Convatec Survey Challenges Assumptions About Leakage in Ostomy Care

LONDON, October 06, 2026--Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today released Rethinking leakage in ostomy care, new international research highlighting a significant gap in how peristomal skin health is understood and managed in ostomy care. The findings indicate that skin health plays a critical role in preventing leakage, and supporting confidence in daily life, yet remains widely under-recognised in routi

Yahoo · Sep 24, 2026

Ostomy Dressing Market Forecasts Growth from $3.80B (2026) to $4.73B by 2031, Profiling Coloplast, ConvaTec, Hollister, B. Braun & Salts Healthcare

The global ostomy dressings market is projected to grow from USD 3.80 billion in 2026 to USD 4.73 billion by 2031, at a 4.4% CAGR. Growth is driven by rising colorectal cancer and inflammatory bowel disease cases, aging populations, improved peristomal skin care awareness, and expanding home care services. Skin barrier rings will record the fastest product growth, while Asia Pacific will be the fastest-growing region. Key companies include Coloplast, ConvaTec, Hollister, B. Braun, Solventum, and

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.